Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Pacira BioSciences, Inc. - Common Stock (NQ:PCRX)

26.41 -0.40 (-1.49%)
Streaming Delayed Price Updated: 12:36 PM EDT, Jul 29, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Pacira BioSciences, Inc. - Common Stock

< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
News headline image
Investors should take notice of NASDAQ:PCRX—it offers a great deal for the fundamentals it presents. ↗
Despite its impressive fundamentals, PACIRA BIOSCIENCES INC (NASDAQ:PCRX) remains undervalued. 
Via Chartmill
News headline image
Pacira Announces FDA Approval of Expanded EXPAREL Label to Include Two Additional Nerve Block Indications
From Pacira BioSciences
Via GlobeNewswire
News headline image
For those who appreciate value investing, NASDAQ:PCRX is a compelling option with its solid fundamentals. ↗
Investors should take notice ofPACIRA BIOSCIENCES INC (NASDAQ:PCRX)—it offers a great deal for the fundamentals it presents. 
Via Chartmill
News headline image
Pacira BioSciences to Participate in Fireside Chat at Two Healthcare Conferences in November
From Pacira BioSciences
Via GlobeNewswire
News headline image
Earnings Preview: Pacira BioSciences ↗
 
Via Benzinga
News headline image
Analyst Expectations for Pacira BioSciences's Future ↗
 
Via Benzinga
News headline image
4 Analysts Have This to Say About Pacira BioSciences ↗
 
Via Benzinga
News headline image
Analyst Ratings for Pacira BioSciences ↗
 
Via Benzinga
News headline image
Pacira BioSciences Reports Third Quarter 2023 Financial Results
From Pacira BioSciences
Via GlobeNewswire
News headline image
Pacira to Report Third Quarter 2023 Financial Results on Thursday November 2, 2023
From Pacira BioSciences
Via GlobeNewswire
News headline image
American Society of Anesthesiologists Announces New Industry Supporter Pacira BioSciences, Inc.
From Pacira BioSciences
Via GlobeNewswire
News headline image
Pacira BioSciences Appoints Four New Independent Directors to its Board of Directors
From Pacira BioSciences
Via GlobeNewswire
News headline image
Looking Into Pacira BioSciences's Return On Capital Employed ↗
 
Via Benzinga
News headline image
Recap: Pacira BioSciences Q1 Earnings ↗
 
Via Benzinga
News headline image
What 6 Analyst Ratings Have To Say About Pacira BioSciences ↗
 
Via Benzinga
News headline image
American Society of Anesthesiologists and Pacira BioSciences, Inc. Announce New Grant to Advance Education and Enhance Patient Care
From Pacira BioSciences
Via GlobeNewswire
News headline image
Pacira BioSciences Announces Leadership Succession Plan
From Pacira BioSciences
Via GlobeNewswire
News headline image
Pacira BioSciences Announces Fireside Chat at the H.C. Wainwright 25th Annual Global Investment Conference
From Pacira BioSciences
Via GlobeNewswire
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
  On Tuesday, 386 stocks made new 52-week lows. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Monday ↗
  Monday's session saw 175 companies set new 52-week lows. 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For August 3, 2023 ↗
 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Friday ↗
  Friday's session saw 225 companies set new 52-week lows. 
Via Benzinga
News headline image
Pacira BioSciences Reports Second Quarter 2023 Financial Results
From Pacira BioSciences
Via GlobeNewswire
News headline image
Pacira to Report Second Quarter 2023 Financial Results on Wednesday August 2, 2023
From Pacira BioSciences
Via GlobeNewswire
News headline image
Pacira BioSciences to Participate in Fireside Chat at the 2023 Jefferies Healthcare Conference
From Pacira BioSciences
Via GlobeNewswire
News headline image
Pacira BioSciences to Participate in Fireside Chat at the 2023 RBC Capital Markets Global Healthcare Conference
From Pacira BioSciences
Via GlobeNewswire
News headline image
Why Pacira BioSciences Shares Are Trading Lower Today ↗
Pacira BioSciences Inc (NASDAQ: PCRX) reported Q1 sales of $160.3 million compared to $158.0 million a year ago and the  
Via Benzinga
News headline image
Pacira BioSciences Reports First Quarter 2023 Financial Results
From Pacira BioSciences
Via GlobeNewswire
News headline image
Pacira to Report First Quarter 2023 Financial Results on Wednesday May 3, 2023
From Pacira BioSciences
Via GlobeNewswire
News headline image
Pacira BioSciences Partners with The Invited Celebrity Classic – a PGA TOUR Champions Event – to Make iovera° The Official Non-Opioid Pain Management Partner
PGA TOUR Champions Golfer, Paul Goydos, Promotes Further Awareness of Non-Opioids with 2023 Partnership 
From Pacira BioSciences
Via GlobeNewswire
< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.